With Wyeth Merger In Beijing's Hands, Pfizer CEO Tours China To Launch Scholarly Partnerships
This article was originally published in The Pink Sheet Daily
Executive Summary
Just days after revealing that the Ministry of Commerce has delayed a decision on approval of the Pfizer-Wyeth merger, Kindler touched down in China to meet with government officials and launch the $1.5 million initiative.